Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents.

about

Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents.

Item

http://www.wikidata.org/entity/Q55366199

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Effectiveness of darbepoetin a ...... herapy including novel agents.

@en

Effectiveness of darbepoetin a ...... herapy including novel agents.

@nl

type

Item

label

Effectiveness of darbepoetin a ...... herapy including novel agents.

@en

Effectiveness of darbepoetin a ...... herapy including novel agents.

@nl

prefLabel

Effectiveness of darbepoetin a ...... herapy including novel agents.

@en

Effectiveness of darbepoetin a ...... herapy including novel agents.

@nl

P1476

Effectiveness of darbepoetin a ...... therapy including novel agents

@en

P2093

Byung-Sik Cho

http://www.w3.org/2001/XMLSchema#string

Chang-Ki Min

http://www.w3.org/2001/XMLSchema#string

Dong-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Je Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Ho Yoon

http://www.w3.org/2001/XMLSchema#string

Jong Wook Lee

http://www.w3.org/2001/XMLSchema#string

Ki-Seong Eom

http://www.w3.org/2001/XMLSchema#string

Seok Lee

http://www.w3.org/2001/XMLSchema#string

Seok-Goo Cho

http://www.w3.org/2001/XMLSchema#string

Sung-Eun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

Symptomatology of anemia.

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

Factors influencing quality of life in cancer patients: anemia and fatigue.

Dose conversion from recombinant human erythropoietin to darbepoetin alfa: recommendations from clinical studies.

Review of 1027 patients with newly diagnosed multiple myeloma.

Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

P304

123-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5045/BR.2018.53.2.123

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29963518

http://www.w3.org/2001/XMLSchema#string

P921

Darbepoetin alfa

P932

6021573

http://www.w3.org/2001/XMLSchema#string